Paper published in a journal (Scientific congresses and symposiums)
#P191 - Long-term follow-up (FU) of health-related quality of life (HRQoL) of patients (pts) with melanoma treated with adjuvant nivolumab (NIVO) in real-world (RW) setting
Rogiers, Anne; Willemot, Laurence; Van Campenhout, Hilde et al.
2026In Pigment Cell and Melanoma Research, 39 (1), p. 70074
Peer Reviewed verified by ORBi
 

Files


Full Text
P191.pdf
Author postprint (563.05 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Rogiers, Anne;  CHU Brugmann
Willemot, Laurence;  BMS - Bristol-Myers Squibb
Van Campenhout, Hilde;  BMS - Bristol-Myers Squibb
Jacobs, Céline;  UZ Gent - Ghent University Hospital
Blockx, Nathalie;  ZNA Middelheim
Rorive, Andrée ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Neyns, Bart;  Universitair Ziekenhuis Brussel
Language :
English
Title :
#P191 - Long-term follow-up (FU) of health-related quality of life (HRQoL) of patients (pts) with melanoma treated with adjuvant nivolumab (NIVO) in real-world (RW) setting
Publication date :
January 2026
Event name :
Society for Melanoma Research 22nd International Congress
Event place :
Amsterdam, Netherlands
Event date :
25-28 October
Journal title :
Pigment Cell and Melanoma Research
ISSN :
1755-1471
eISSN :
1755-148X
Publisher :
Wiley
Volume :
39
Issue :
1
Pages :
e70074
Peer review/Selection committee :
Peer Reviewed verified by ORBi
Available on ORBi :
since 27 February 2026

Statistics


Number of views
7 (0 by ULiège)
Number of downloads
5 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi